Aesthetic Medical International Holdings Group Limited
Other OTCTotal Valuation
Aesthetic Medical International Holdings Group Limited carries a market capitalization of 243,438.00, placing it among publicly traded companies globally. Its enterprise value stands at 522.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 243,438.00 |
| Enterprise Value | 522.28M |
Share Statistics
Aesthetic Medical International Holdings Group Limited currently has 142.67M shares outstanding.
| Shares Outstanding | 142.67M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.47, and the price-to-book ratio stands at -0.27.
| PE Ratio | N/A |
| PS Ratio | 0.47 |
| PB Ratio | -0.27 |
| P/TBV Ratio | -65.85 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 0.80 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 48.53 |
Financial Position
Aesthetic Medical International Holdings Group Limited maintains a current ratio of 0.35, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,000.78, indicating moderate leverage, while an interest coverage ratio of -2.85 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.35 |
| Quick Ratio | 0.22 |
| Debt / Equity | 1,000.78 |
| Debt / EBITDA | -7.84 |
| Interest Coverage | -2.85 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -13.94 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 12.65 |
Taxes
| Income Tax | -27.37M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Aesthetic Medical International Holdings Group Limited's stock has declined approximately -92.85714% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92.85714% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Aesthetic Medical International Holdings Group Limited generated 650.80M in revenue and converted that into -81.70M in net income, yielding earnings per share of -2.09. EBITDA reached -40.65M, while operating income came in at -40.65M.
| Revenue | 650.80M |
| Gross Profit | 318.65M |
| Operating Income | -40.65M |
| Pretax Income | -111.08M |
| Net Income | -81.70M |
| EBITDA | -40.65M |
| EBIT | -40.65M |
| Earnings Per Share (EPS) | -2.09 |
Balance Sheet
Aesthetic Medical International Holdings Group Limited holds 87.88M in cash and equivalents against 318.89M in total debt, resulting in a net debt position of 118.17M. Total book value stands at -1.15B, with working capital of -297.47M providing operational flexibility.
| Cash & Cash Equivalents | 87.88M |
| Total Debt | 318.89M |
| Net Debt | 118.17M |
| Equity (Book Value) | -1.15B |
| Book Value Per Share | -28.69 |
| Working Capital | -297.47M |
Margins
Aesthetic Medical International Holdings Group Limited operates with a gross margin of 48.96, reflecting its pricing power and cost economics. The operating margin of -6.25 and net profit margin of -12.55 provide insight into operational efficiency.
| Gross Margin | 48.96 |
| Operating Margin | -6.25 |
| Pretax Margin | -17.07 |
| Profit Margin | -12.55 |
| EBITDA Margin | -6.25 |
Scores
Aesthetic Medical International Holdings Group Limited posts an Altman Z-Score of -2.24, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.24 |